Which ETFs hold Lakefront Biotherapeutics NV?
LKFT is held by 2 of the 504 ETFs we cover. The heaviest allocation is IBB at 0.1%; among the largest funds, AVDE holds 0.0%. The median weight across all funds holding it is 0.0%.
- Covered ETFs Holding It
- 2
- Heaviest Allocation
- 0.10%in IBB
- Median Weight
- 0.01%across funds that hold it
Funds Holding LKFT(2)
| ETF | |||||||
|---|---|---|---|---|---|---|---|
| IBBiShares Biotechnology ETF | 0.10% | 0.44% | $9.3B | 0.21% | +17.3% | +51.0% | +3.1% |
| AVDEAvantis International Equity ETF | 0.01% | 0.23% | $18.2B | 2.35% | +15.8% | +27.7% | +11.2% |
Expense = net expense ratio from the fund's latest SEC prospectus filing. YTD/1Y/5Y are trailing total returns including dividends (5Y annualized, as of 2026-08-07). Past performance does not predict future results. Sort by any column.
Frequently Asked Questions
Which ETF has the most LKFT exposure?
IBB has the heaviest LKFT allocation of the ETFs we cover, at 0.10% of its portfolio, based on the fund's latest SEC-reported holdings.
How many ETFs hold LKFT?
2 of the 504 ETFs we cover hold Lakefront Biotherapeutics NV (LKFT). The median weight across those funds is 0.01%.
What is the cheapest ETF that holds LKFT?
AVDE has the lowest expense ratio among covered ETFs holding LKFT, at 0.23% per year.
What is the largest ETF that holds LKFT?
AVDE (Avantis International Equity ETF) is the largest covered ETF holding LKFT, with $18.2B in assets and a 0.01% position.
Keep Exploring
Look up another stock or compare two of these ETFs to see how much they overlap beyond LKFT.